Cargando…
1086. COVID-19 in a Comprehensive Cancer Center: 2020-2022
BACKGROUND: Patients with COVID-19 and underlying malignancies, particularly those receiving immunosuppressive therapy, are at higher risk of severe COVID-19 disease. Our retrospective cohort study examines the outcomes of COVID-19 infection in patients with different underlying malignancies admitte...
Autores principales: | Mulanovich, Patricia, Chemaly, Roy F, Granwehr, Bruno, McConn, Kelly, Assistant, Physician, Patel, Nina, Raad, Issam I, Adachi, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751911/ http://dx.doi.org/10.1093/ofid/ofac492.926 |
Ejemplares similares
-
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts
por: Malek, Alexandre E., et al.
Publicado: (2020) -
1786. Safety, Efficacy, and Clinical Impact of Penicillin Allergy Skin Testing in Immunocompromised Cancer Patients at a Comprehensive Cancer Center
por: Artau, Annette, et al.
Publicado: (2018) -
SAT129 Clinical Conundrum Of Suspected Pancreatitis Masking Diabetic Ketoacidosis
por: Sood, Aayushi, et al.
Publicado: (2023) -
1086 CORONAVIRUS-LIKE PARTICLES AND NEONATAL GASTROINTES-TINAL DISEASE
por: Vaucher, Yvonne E, et al.
Publicado: (1981) -
1086. Antimicrobial Stewardship: From Bedside to Man’s Best Friend
por: Reed, Erica E, et al.
Publicado: (2019)